Westhampton Capital’s Zimmer Biomet ZBH Stock Holding History

Westhampton Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,845	Closed	-$200K	–	120
2024 Q2	$200K	Hold	1,845	–	–	0.11%	114
2024 Q1	$243K	Hold	1,845	–	–	0.13%	109
2023 Q4	$225K	Sell	1,845 -700	-28%	-$78.1K	0.13%	112
2023 Q3	$286K	Hold	2,545	–	–	0.18%	99
2023 Q2	$371K	Sell	2,545 -1,190	-32%	-$162K	0.24%	86
2023 Q1	$483K	Hold	3,735	–	–	0.31%	87
2022 Q4	$476K	Sell	3,735 -115	-3%	-$13.3K	0.32%	80
2022 Q3	$402K	Sell	3,850 -1,275	-25%	-$140K	0.3%	86
2022 Q2	$538K	Sell	5,125 -99	-2%	-$11.7K	0.38%	74
2022 Q1	$668K	Buy	5,224 +925	+22%	+$111K	0.43%	70
2021 Q4	$530K	Buy	4,299 +2,229	+108%	+$292K	0.32%	82
2021 Q3	$294K	Buy	+2,070	New	+$305K	0.2%	99

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Westhampton Capital's ZBH Position: Q3 2024 in Review

Westhampton Capital sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 1,845 shares — an estimated $200K sold.

Westhampton Capital first reported a position in ZBH in Q3 2021 and held it in 12 quarters. The position peaked at $668K in Q1 2022. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Westhampton Capital reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Westhampton Capital sold 1,845 Zimmer Biomet shares in Q3 2024, an estimated $200K.
Westhampton Capital first reported a position in Zimmer Biomet in Q3 2021 and held it in 12 quarters.
Westhampton Capital's Zimmer Biomet position peaked at $668K in Q1 2022.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Westhampton Capital's 13F filing for Q3 2024, filed 22 Oct 2024.